FLT3 mutation-related immune checkpoint molecule absent in melanoma 2 (AIM2) contributes to immune infiltration in pediatric and adult acute myeloid leukemia: evidence from bioinformatics analysis
Jing Zhao, Yue Cui, Hua Zhou, Dongming Zhou, Zhiping Che, Ning Zhang, Qi Yun, João Agostinho Machado-Neto, Daniela Damiani, Lika’a Fasih Y. Al-Kzayer, Rohan Kulkarni, Meng Gu · 2024
Read FLT3 mutation-related immune checkpoint molecule absent in melanoma 2 (AIM2) contributes to immune infiltration in pediatric and adult acute myeloid leukemia: evidence from bioinformatics analysis by Jing Zhao, Yue Cui, Hua Zhou, Dongming Zhou, Zhiping Che, Ning Zhang, Qi Yun, João Agostinho Machado-Neto, Daniela Damiani, Lika’a Fasih Y. Al-Kzayer, Rohan Kulkarni, Meng Gu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11651761.txt.
Description
Jing Zhao and co-authors mine, in a 2024 study, large databases to link a leukemia gene fault to an immune sensor. The gene, FLT3, is a known drug target in acute myeloid leukemia, but its tie to immune infiltration was unclear. The team searched cancer and tissue datasets for immune checkpoint molecules that shift when FLT3 is mutated.
One sensor, AIM2, stood out. It ran high in patients with the mutation, and its rise tracked with a worse course and a more muted immune scene. Its level also tracked with how cells respond to drugs in laboratory tests. Maps of its connections tied it to pathways for immune signaling and inflammation. Counts of immune cells placed it beside several cell types that can calm immune attack. The authors name AIM2 as a promising drug target to pair with FLT3 blockers.
Catalog record
| CREATOR | Jing Zhao, Yue Cui, Hua Zhou, Dongming Zhou, Zhiping Che, Ning Zhang, Qi Yun, João Agostinho Machado-Neto, Daniela Damiani, Lika’a Fasih Y. Al-Kzayer, Rohan Kulkarni, Meng Gu |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |